Year |
Citation |
Score |
2023 |
Henning NJ, Manford AG, Spradlin JN, Brittain SM, Zhang E, McKenna JM, Tallarico JA, Schirle M, Rape M, Nomura DK. Correction to "Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications". Journal of the American Chemical Society. 145: 21142. PMID 37708357 DOI: 10.1021/jacs.3c09174 |
0.791 |
|
2023 |
Moon P, Zammit C, Shao Q, Boike L, Dovala D, Henning NJ, Knapp M, Spradlin JN, Ward CC, Wolleb H, Fuller D, Blake G, Murphy JP, Wang F, Lu Y, et al. Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors. Chembiochem : a European Journal of Chemical Biology. e202300116. PMID 37069799 DOI: 10.1002/cbic.202300116 |
0.648 |
|
2022 |
Du G, Jiang J, Henning NJ, Safaee N, Koide E, Nowak RP, Donovan KA, Yoon H, You I, Yue H, Eleuteri NA, He Z, Li Z, Huang HT, Che J, et al. Exploring the target scope of KEAP1 E3 ligase-based PROTACs. Cell Chemical Biology. PMID 36070758 DOI: 10.1016/j.chembiol.2022.08.003 |
0.51 |
|
2022 |
Boike L, Henning NJ, Nomura DK. Advances in covalent drug discovery. Nature Reviews. Drug Discovery. PMID 36008483 DOI: 10.1038/s41573-022-00542-z |
0.748 |
|
2022 |
Henning NJ, Boike L, Spradlin JN, Ward CC, Liu G, Zhang E, Belcher BP, Brittain SM, Hesse MJ, Dovala D, McGregor LM, Valdez Misiolek R, Plasschaert LW, Rowlands DJ, Wang F, et al. Deubiquitinase-targeting chimeras for targeted protein stabilization. Nature Chemical Biology. PMID 35210618 DOI: 10.1038/s41589-022-00971-2 |
0.621 |
|
2022 |
Henning NJ, Manford AG, Spradlin JN, Brittain SM, Zhang E, McKenna JM, Tallarico JA, Schirle M, Rape M, Nomura DK. Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications. Journal of the American Chemical Society. 144: 701-708. PMID 34994556 DOI: 10.1021/jacs.1c03980 |
0.803 |
|
2021 |
Du G, Jiang J, Wu Q, Henning NJ, Donovan KA, Yue H, Che J, Lu W, Fischer ES, Bardeesy N, Zhang T, Gray NS. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. Angewandte Chemie (International Ed. in English). PMID 33915015 DOI: 10.1002/anie.202101328 |
0.335 |
|
2020 |
Boike L, Cioffi AG, Majewski FC, Co J, Henning NJ, Jones MD, Liu G, McKenna JM, Tallarico JA, Schirle M, Nomura DK. Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC. Cell Chemical Biology. PMID 32966806 DOI: 10.1016/j.chembiol.2020.09.001 |
0.673 |
|
2020 |
Du G, Rao S, Gurbani D, Henning NJ, Jiang J, Che J, Yang A, Ficarro SB, Marto JA, Aguirre AJ, Sorger PK, Westover KD, Zhang T, Gray NS. Structure-based design of a potent and selective covalent inhibitor for SRC kinase that targets a p-Loop cysteine. Journal of Medicinal Chemistry. PMID 31935084 DOI: 10.1021/Acs.Jmedchem.9B01502 |
0.359 |
|
Show low-probability matches. |